The South Korea nebulizer market is anticipated to grow at a CAGR of 5.40% during the forecast period of 2025-2034, driven by the growing ageing population and an increase in the prevalence of various respiratory disorders across the region.
Base Year
Historical Year
Forecast Year
The market is poised for steady growth due to increasing respiratory disorders, rising pollution levels, and a growing elderly population requiring advanced aerosol-based drug delivery solutions.
Technological advancements in portable and smart nebulizers, coupled with expanding healthcare infrastructure and government support for respiratory care, are expected to drive market expansion in South Korea.
Rising awareness of respiratory health, increasing adoption of home-based nebulization therapy, and the availability of cost-effective nebulizer devices will contribute to market penetration and long-term growth.
A nebulizer is a medical device that converts liquid medication into a fine mist, allowing it to be inhaled directly into the lungs. It is commonly used to treat respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and other lung disorders. Nebulizers are especially beneficial for young children, elderly patients, and those with difficulty using inhalers. Available in jet, ultrasonic, and mesh types, they provide effective and consistent drug delivery. Portable and tabletop models ensure accessibility, making nebulizers essential for respiratory therapy at home and in clinical settings.
Growing Elderly Population with Severe Asthma to Drive Market Expansion
The increasing geriatric population and rising prevalence of severe asthma among older adults are key drivers of nebulizer market growth in South Korea. A study published by the Korean Severe Asthma Registry (KoSAR) in March 2024 found that elderly SA patients (≥ 65 years) had lower lung function, higher comorbidity with COPD, and less frequent use of biologics compared to younger patients. Given these challenges, nebulizers remain a critical treatment option for elderly SA patients who require long-term, efficient respiratory therapy. As South Korea’s ageing population grows, the demand for nebulizers in home care and hospitals is expected to increase, supporting market expansion.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
South Korea Nebulizer Market Report and Forecast 2025-2034 offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Portability
Market Breakup by Application
Market Breakup by Distribution Channel
Market Breakup by End User
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Jet Nebulizers Leading the Segment by Type
Jet nebulizers are set to dominate the market due to their affordability, widespread availability, and effectiveness in delivering medication for chronic respiratory conditions. Their strong adoption in hospitals and homecare settings is driven by increasing cases of asthma and COPD. Technological advancements improving efficiency and drug delivery further support market expansion. As South Korea's ageing population grows, along with rising pollution levels, the demand for effective respiratory treatment solutions will boost jet nebulizer sales, making them the leading product type in the forecast period.
Portable Nebulizers to Lead the South Korea Nebulizer Market Segmentation by Portability
Portable nebulizers are expected to hold the largest market share in South Korea due to their convenience, compact design, and growing preference for at-home respiratory care. Their rising adoption among the elderly and individuals with chronic conditions reflects the increasing need for mobility-friendly treatment solutions. Improvements in battery life and medication delivery efficiency further enhance their market appeal. As South Korea continues to experience a rising prevalence of respiratory disorders, the demand for portable nebulizers is poised to surge, solidifying its dominance in the forecast period.
Asthma Leading the Segment by Application
Asthma is expected to lead the South Korea nebulizer market, driven by its high prevalence, worsening air quality, and rising allergen exposure. According to the WHO (May 2024) , asthma is a major noncommunicable disease (NCD) affecting both children and adults, making it the most common chronic illness among children. Inflammation and narrowing of the small airways cause symptoms like cough, wheezing, and breathlessness, increasing the demand for nebulizers. As per the analysis by Expert Market Research, the global asthma treatment market is likely to grow further at a CAGR of 4.6% during the forecast period of 2025-2034. Government efforts promoting early diagnosis and respiratory care advancements further fuel market growth. As South Korea’s ageing population faces respiratory vulnerabilities, asthma-related nebulizer adoption will continue to rise in the forecast period.
Hospital Pharmacies to Lead the South Korea Nebulizer Market Share by Distribution Channel
Hospital pharmacies are expected to dominate the market as the primary distribution channel due to their association with trusted healthcare providers and assured product authenticity. Hospitals are key points of care for severe respiratory conditions, ensuring high patient demand for nebulizers. Increasing hospitalisation rates for respiratory disorders and the presence of advanced medical infrastructure further drive sales through this channel. As South Korea’s healthcare sector advances, with improved patient access to treatment, hospital pharmacies will continue to be the most significant distribution segment in the forecast period.
Hospitals and Clinics to Lead the South Korea Nebulizer Market Segment by End User
Hospitals and clinics are poised to hold the largest market share in the market due to the rising number of hospital admissions for respiratory illnesses. The availability of advanced nebulisation technology, trained healthcare professionals, and immediate medical intervention strengthens their dominance. Government healthcare initiatives and increasing investments in hospital infrastructure further contribute to segment growth. As South Korea continues to enhance its medical facilities and respiratory care services, hospitals and clinics will drive the highest demand for nebulizers in the forecast period.
The Seoul metropolitan region is poised to lead the market, driven by its advanced healthcare infrastructure, high prevalence of respiratory diseases, and growing elderly population. The region accounts for a significant share of South Korea’s healthcare facilities, with numerous hospitals, clinics, and research institutions specialising in respiratory care. Additionally, increasing air pollution levels in Seoul contribute to rising cases of asthma and chronic obstructive pulmonary disease (COPD), boosting nebulizer demand. Government initiatives promoting home healthcare, and the adoption of portable nebulizers further strengthen market growth. With high consumer awareness, technological advancements, and a strong distribution network, the Seoul Metropolitan Region is expected to dominate the market during the forecast period.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Omron Corporation, headquartered in Kyoto, Japan, was founded in 1933. It is a global leader in healthcare technology, specialising in medical devices such as nebulizers, blood pressure monitors, and respiratory care solutions. Omron’s nebulizers are widely used for treating respiratory conditions, offering innovative mesh and compressor nebulisation technology for efficient drug delivery. With a strong focus on digital health and preventive care, Omron continues to enhance respiratory management solutions. The company prioritises AI-driven healthcare advancements, expanding its presence in the nebulizer market through reliable, high-performance products designed for both home and clinical use.
GE HealthCare, a subsidiary of General Electric, is headquartered in Chicago, USA, and was officially established as an independent company in 2023. It specialises in medical imaging, patient monitoring, and respiratory care solutions, including advanced nebulizers for treating respiratory conditions. GE HealthCare’s nebulisation technology integrates precision engineering with innovative aerosol therapy to improve drug delivery efficiency. With a strong focus on digital transformation, AI-driven diagnostics, and connected healthcare solutions, the company continues to develop advanced respiratory care devices, strengthening its presence in the nebulizer market and enhancing global patient outcomes.
Koninklijke Philips N.V., headquartered in Amsterdam, Netherlands, was founded in 1891. A global leader in healthcare technology, it offers a diverse portfolio, including respiratory care solutions such as nebulizers, oxygen concentrators, and sleep therapy devices. Philips provides high-quality mesh and compressor nebulizers designed for efficient drug delivery in asthma, COPD, and other respiratory conditions. With a strong focus on patient-centred innovations, digital health, and homecare solutions, Philips continues to expand its nebulizer market presence, improving respiratory treatment accessibility and efficiency through advanced, user-friendly medical devices.
KTMED INC., a South Korean medical device manufacturer, was established in 1995 and is headquartered in Gyeonggi-do, South Korea. The company specialises in developing high-quality respiratory therapy devices, including nebulizers, oxygen therapy equipment, and suction machines. KTMED’s nebulizers are known for their efficiency, durability, and ease of use, catering to both home and clinical settings. With a commitment to research and innovation, KTMED continuously enhances its respiratory care portfolio, strengthening its presence in domestic and international markets while contributing to advancements in nebulisation therapy and respiratory healthcare solutions.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Boditech Med Inc., Teleflex Incorporated, Vectura Group Ltd, DeVilbiss Healthcare LLC., and Allied Healthcare.
South Korea Nebulizer Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2024 |
| Historical Period | 2018-2024 |
| Forecast Period | 2025-2034 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Portability |
|
| Breakup by Application |
|
| Breakup by Distribution Channel |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-723-689-1189
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share